hers glp 1 oral Hims & copies Novo Nordisk's new Wegovy pill Hers introduces GLP-1 weight loss

2 Data from the largest clinical trial of GLP-1s to date (the SELECT trial of nearly 18,000 participants) showed in November 2023 that Wegovy (Novo Nordisks GLP-1 for weight loss) reduced heart attacks, strokes and deaths due to cardiovascular disease and drove a 73% reduction in the progression toward diabetes versus the control group

Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas

You invest time and expertise, not a clinic infrastructure

Specific indicators include jowls extending more than one centimeter below the jawline, loose neck skin with visible banding, and skin that does not snap back when pinched